The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Δημοσίευση

The use of antenatal corticosteroids for fetal maturation: clinical practice guideline by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine foundation.

TitleThe use of antenatal corticosteroids for fetal maturation: clinical practice guideline by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine foundation.
Publication TypeJournal Article
Year of Publication2022
AuthorsDagklis, T., Sen C., Tsakiridis I., Villalaín C., Allegaert K., Wellmann S., Kusuda S., Serra B., Luna M. Sanchez, Huertas E., Volpe N., Ayala R., Jekova N., Grunebaum A., & Stanojevic M.
JournalJ Perinat Med
Volume50
Issue4
Pagination375-385
Date Published2022 May 25
ISSN1619-3997
KeywordsAdrenal Cortex Hormones, Female, Fetal Development, Humans, Pregnancy, Premature Birth, Prenatal Care
Abstract

This practice guideline follows the mission of the World Association of Perinatal Medicine in collaboration with the Perinatal Medicine Foundation, bringing together groups and individuals throughout the world, with the goal of improving the use of antenatal corticosteroids (ACS) for fetal maturation. In fact, this document provides further guidance for healthcare practitioners on the appropriate use of ACS with the aim to increase the timely administration and avoid unnecessary or excessive use. Therefore, it is not intended to establish a legal standard of care. This document is based on consensus among perinatal experts throughout the world and serves as a guideline for use in clinical practice.

DOI10.1515/jpm-2022-0066
Alternate JournalJ Perinat Med
PubMed ID35285217

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.